Abstract:Background: Chemotherapy is currently one of the most common/important treatments for cancers; however the occurrence of multidrug resistance (MDR) impedes the successful application of chemotherapeutic agents. The active efflux of anti-cancer drugs through multi-drug resistance protein 1 (MRP1) remains the dominant mechanism of MDR. However, mechanisms underlying the MRP1 upregulation during tumorigenesis and chemotherapy remain elusive. Methods: MRP1 expression, the efflux probability and viability were measured to evaluate MDR of human lung cancer A549/DDP and H1299 cells. Pharmacological treatment, shRNA-based konckdown and rescue were used to assess the function of JNK (c-Jun N-terminal kinase) and Sp1 (stimulatory phosphatase 1). Chromatin immunoprecipitation and dual-luciferase reporter assay were used to test the direct binding and activation of MRP1 promotor by Sp1. Findings: Pharmacological analysis and JNK knockdown revealed the direct modulation of MRP1 expression and MDR by by the JNK signaling pathway. Furthermore, the transcript factor Sp1 downstream of JNK showed close association with MRP1 expression and MDR. Chromatin immunoprecipitation and luciferase assays revealed the direct binding and activation of MRP1 promoter by Sp1, while Sp1 knockdown decreased MRP1 expression and reversed MDR. Importantly, the MRP1 upregulation and MDR mediated by JNK activation were substantially abolished by Sp1 knockdown in both A549/DDP and H1299 cells. Interpretation: This work demonstrates that Sp1 is a critical transcription factor for MRP1 downstream of JNK and plays a key role in MRP1 upregulation and MDR during tumorigenesis and chemotherapy. Targeting Sp1 expression/activation sheds new light on the clinical chemotherapy treatments of cancers.Funding Statement: This work was supported by the National Natural Science Foundation of China (31400708 and 31670843), the Natural Science Foundation of Heilongjiang Province, China (C200624, C201241, and C201453), the Shaanxi Natural Science Funds for Distinguished Young Scholars of China (2019JC-07), the Key Research and Development Program of Shaanxi Province, China (2017SF-113), and the Fundamental Research Funds for the Central Universities (2017qngz10).Declaration of Interests: The authors declare no competing financial interests.Ethics Approval Statement: Not required.

PP 1 Cooperates with ASPP 2 to dephosphorylate and activate

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Plenary Paper

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

1 POLYCOMB GROUP PROTEIN PHF 1 REGULATES P 53-DEPENDENT CELL GROWTH ARREST AND APOPTOSIS

Dddt_a_209481 3079..3089

SP1 Mediates MRP1 Upregulation and Multi-Drug Resistance in Human Lung Cancer Cells

Editorial: Novel Insights in RNA Modifications: from Basic to Translational Research

CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells

Cmar_a_195964 5187..5195

Ott_a_242517 1757..1765

PP2A-Mediated Anticancer Therapy.

HEMATOPOIESIS AND STEM CELLS A motif in LILRB 2 critical for Angptl 2 binding and activation

NSUN 2-mediated m 5 C methylation and METTL 3 / METTL 14-mediated m 6 A methylation cooperatively enhance p 21 translation † Running Title : NSUN 2 and METTL 3 / METTL 14 regulate p 21 translation

ASPP1/2-PP1 Complexes Are Required for Chromosome Segregation and Kinetochore-Microtubule Attachments

Cmar_a_192845 3053..3060

Cmar_a_197052 3993..4003

Apak competes with p 53 for direct binding to intron 1 of p 53 AIP 1 to regulate apoptosis

Cmar_a_197544 6365..6376

Cmar_a_197337 6343..6351

PTPN 9 in erythroid development 2